Translational Drug Development (TD2)
TD2 provides innovative services for the improved and accelerated development of therapies for cancer. Our team has deep experience and understanding of drug development. Preclinical development, combined with strategic regulatory consultation, guides customized clinical trial design and execution. Our capabilities encourage the timely selection of patient populations who are most likely to benefit from a new agent and the rapid identification of clinically significant endpoints. Work with a team that believes in your research as much as you do.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No